09 May2024Approximately USD 10.8 Million Invested in New Drug Development for Malaria and NTDs in Partners Including Japanese Pharma Shionogi, Mitsubishi Tanabe, and Eisai and Europe-Based InstitutionsAuthor By Healthufit Posted on May 9, 2024May 9, 2024Approximately USD 10.8 Million Invested in New Drug Development for Malaria...